ULB Hôpital Erasme Département de Néphrologie
About ULB Hôpital Erasme Département de Néphrologie
Erasmus Hospital is a hospital in the Anderlecht municipality of Brussels, Belgium. It is a teaching hospital associated with the Université libre de Bruxelles, and was opened in 1977. It has 858 beds and 3000 staff, treating 26,000 inpatients and 260,000 outpatients each year.
There are 858 beds in ULB Hôpital Erasme Département de Néphrologie.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Henogen
4
Clinical Trials at ULB Hôpital Erasme Département de Néphrologie
During the past decade, ULB Hôpital Erasme Département de Néphrologie conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to GSK Biologicals Adjuvanted Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Have Not Been Exposed to Hepatitis B.
2006-02-01
2007-03-01
Completed
300
Compare the Immune Response & Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine vs Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis & Dialysis Patients Who Did Not Respond to Previous Hepatitis B Vaccination
2006-03-01
2007-10-01
Completed
257
A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Responded to Previous Hepatitis B Vaccination But Lost Antibody.
2006-03-01
2007-10-01
Completed
185
Study Evaluating Persistence of Anti-HBs Antibodies in Uraemic Patients Receiving Henogen's HBV Vaccine, or Fendrix™
2007-03-01
2009-11-01
Completed
102
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "ULB Hôpital Erasme Département de Néphrologie"
#1 collaborator was "GlaxoSmithKline" with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at ULB Hôpital Erasme Département de Néphrologie
According to Clinical.Site data, the most researched conditions in "ULB Hôpital Erasme Département de Néphrologie" are
"Hepatitis B" (4 trials). Many other conditions were trialed in "ULB Hôpital Erasme Département de Néphrologie" in a lesser frequency.
Clinical Trials Intervention Types at ULB Hôpital Erasme Département de Néphrologie
Most popular intervention types in "ULB Hôpital Erasme Département de Néphrologie" are "Biological" (4 trials). Other intervention types were less common.
The name of intervention was led by "HBVAXPRO vaccine" (2 trials), "FENDRIX" (1 trials), "Fendrix vaccine" (1 trials), "HB-AS02V" (1 trials) and "HB-AS02V vaccine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at ULB Hôpital Erasme Département de Néphrologie
The vast majority of trials in "ULB Hôpital Erasme Département de Néphrologie" are
4 trials for "All" genders.
Clinical Trials Status at ULB Hôpital Erasme Département de Néphrologie
Currently, there are NaN active trials in "ULB Hôpital Erasme Département de Néphrologie".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in ULB Hôpital Erasme Département de Néphrologie,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in ULB Hôpital Erasme Département de Néphrologie, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".